TECH - BIO-TECHNE Corp
55.89
-1.960 -3.507%
Share volume: 2,482,147
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$57.85
-1.96
-0.03%
Summary score
40%
Profitability
24%
Dept financing
40%
Liquidity
37%
Performance
56%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
1.91%
Return on assets
2.06%
Return on sales
22.07%
Return on invested capital
1.63%
Total debt ratio
39.88%
Debt ratio change over timeo
0%
Current Ratio
2.59%
Quick Ratio
2.04%
Cash Position Ratio
0.58%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
1.94%
Return on assets
2.12%
Return on sales
22.25%
Return on invested capital
1.66%
Total debt ratio
39.6%
Debt ratio change over timeo
0%
Current Ratio
2.51%
Quick Ratio
1.99%
Cash Position Ratio
0.57%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
1.65%
Return on assets
2.33%
Return on sales
24.59%
Return on invested capital
1.42%
Total debt ratio
37.16%
Debt ratio change over time
0%
Current Ratio
2.87%
Quick Ratio
2.25%
Cash Position Ratio
0.68%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TECH | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 1.91% | 6.52% | 16.07% | 8% |
| Return on assets | 2.06% | 3.2% | 7.46% | 5.12% |
| Return on sales | 22.07% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | 1.63% | 9.05% | 13.06% | 8.23% |
| Profitability | 22% | 57% | 100% | 63% |
| Total debt ratio | 39.88% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 40% | 23% | 25% | 18% |
| Current Ratio | 2.51% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 1.99% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 0.57% | 0.33% | 1.09% | 0.45% |
| Liquididy | 39% | 58% | 52% | 38% |
| Short-term ratios | TECH | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 1.94% | 6.57% | 13.54% | 7.21% |
| Return on assets | 2.12% | 3.23% | 6.63% | 5.05% |
| Return on sales | 22.25% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | 1.66% | 9.41% | 12.01% | 7.62% |
| Profitability | 25% | 63% | 100% | 66% |
| Total debt ratio | 39.6% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 41% | 24% | 25% | 18% |
| Current Ratio | 2.51% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 1.99% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 0.57% | 0.33% | 1.09% | 0.45% |
| Liquididy | 35% | 58% | 54% | 32% |